Stegsita-M50 Tablet
By Stegsita-M
Rx
15 Tablet in a Strip

Composition
Sitagliptin(50mg) + Metformin(500mg)

Manufacturer - Metalis Lifesciences Pvt Ltd
12B,Sita Estate, Aziz Baug, Chembur Mumbai-400074. Maharashtra , India

Expires on or after
October, 2025

liver
"Stegsita-M50 Tablet may not be safe for individuals with liver disease and should be avoided. It is important to seek advice from your doctor before using this medication."

kidney
Stegsita-M50 Tablet requires caution in patients with kidney disease. Dose adjustment may be necessary, but it's not advised for severe kidney disease. Regular kidney function tests are recommended during treatment. Consult your doctor for proper guidance.

alcohol
Avoid consuming alcohol while taking Stegsita-M50 Tablet. Drinking alcohol may increase the risk of side effects.

driving
If you experience low or high blood sugar, avoid driving while taking Stegsita-M50 Tablet to prevent impaired focus and reaction time.

pregnancy
Stegsita-M50 Tablet may be unsafe during pregnancy. Animal studies show potential harm to the developing baby. Your doctor will assess the risks and benefits before prescribing. Please consult your doctor.

breastfeeding
Stegsita-M50 Tablet is likely unsafe during breastfeeding as it may pass into breastmilk and harm the baby. It is better to consult your doctor before using Stegsita-M50 Tablet.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹142.5
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024